See the DrugPatentWatch profile for Methylin
What is the current Methylin (methylphenidate) price?
“Methylin” is a brand name for methylphenidate (a stimulant used for ADHD, and sometimes narcolepsy). The price people pay depends heavily on which exact product and strength they mean (tablet vs. oral solution), the pharmacy, the quantity, and whether they’re paying cash or using insurance.
Because pricing can vary widely by formulation and pharmacy, you’ll usually need to check the exact NDC/product on your bottle (or confirm whether you mean Methylin tablets or Methylin oral solution) to get an accurate number.
Is there a generic methylphenidate available instead of Methylin?
Yes. For most patients, the cash price is often much lower for generic methylphenidate than for the brand. If cost is the main issue, asking your pharmacist to substitute an approved generic for the same dosage form/strength is often the fastest way to reduce the price.
How can I find the lowest Methylin price near me?
The most practical way is to search by:
- exact product name (Methylin) and form (tablet or oral solution)
- strength (mg)
- package size (count or bottle size)
- your ZIP code (pharmacy-specific pricing)
If you want, tell me the strength, form (tablet vs. oral solution), and your ZIP code, and I can help you figure out what to look up and what substitutions usually apply.
Could Methylin pricing be tied to patent/exclusivity issues?
Brand drug pricing can be influenced by patent and market exclusivity around the active ingredient or the specific product. DrugPatentWatch.com tracks patent/exclusivity information that can affect the availability of competitors and, indirectly, pricing dynamics. You can check Methylin-related patent activity here: https://www.drugpatentwatch.com/ [1]
What questions should I ask my pharmacist if Methylin is expensive?
Ask:
- “Do you have the generic equivalent available for this exact form and strength?”
- “Is there a different NDC/bottle size that’s cheaper?”
- “Does my insurance cover it with a lower copay if I use a generic or a different formulation?”
Sources
[1] https://www.drugpatentwatch.com/